Delivery Order SPE2DB22D1202-SPE2DB24FVKP1

Award Date 8/12/24
Potential Completion Date 8/13/24
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for 4,566,564,050 units of 40mg Vyvanse capsules, a prescription medication, at a firm fixed price of $23,792.05. The order has a completion date of November 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Vyvanse 20 mg capsules. The contract, valued at $4,297.28, is a Firm Fixed Price Delivery Order with a completion date of June 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division, a major pharmaceutical supplier to the U.S. federal government. The contract, valued at $5,216.58, is for the delivery of 100 capsules of the prescription drug Vyvanse 20 mg. The contract has a firm fixed price pricing type and a completion date of August 1, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Vyvanse 40 mg capsules. The contract has a ceiling value of $4,700.14 and a period of performance through April 30, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle through December 2026....
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,567.20 firm fixed-price contract is for the delivery of 100 units of the medication Vyvanse 20mg. The contract has an ultimate completion date of June 27, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, designated as SPE2DX, which provides a comprehensive...
This is a $7,758 firm-fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The order is for the supply of 4,565,389,732 units of Vyvanse 30 mg capsules. The contract has an ultimate completion date of August 9, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) worth up to $999,999,999 with DLA Troop Support Medical for delivering a comprehensive range of medical commodities to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,162.05, is for the supply of Vyvanse 60 mg capsules. It is a firm-fixed-price contract with an ultimate completion date of April 2, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 40 mg capsules of the prescription medication Vyvanse, with a ceiling value of $1,945.53 and a period of performance through May 19, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Vyvanse 60 mg capsules. The order, valued at $1,047.82, is a firm-fixed price contract with a completion date of September 23, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,758.99, is for the delivery of 100 units of the medication Vyvanse 30 mg capsule. The contract has an ultimate completion date of April 24, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FVKP1
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,893.68, is for the supply of 100 units of the 40 mg capsule form of the drug Vyvanse. The contract has an ultimate completion date of August 13, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, which serve as primary vehicles for providing a wide range of pharmaceutical and medical supplies to support military treatment programs, veterans' healthcare, and other federal healthcare needs nationwide.

Generated 11/11/24, 9:22 AM